Engineers Gate Manager’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Engineers Gate Manager’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-44,639	Closed	-$136K	–	2384
2023 Q4	$136K	Buy	44,639 +30,281	+211%	+$56.9K	﹤0.01%	1720
2023 Q3	$20.7K	Buy	+14,358	New	+$27.8K	﹤0.01%	1706
2023 Q1	–	Sell	-46,551	Closed	-$253K	–	2084
2022 Q4	$253K	Buy	46,551 +20,190	+77%	+$169K	0.02%	1264
2022 Q3	$329K	Buy	26,361 +4,674	+22%	+$53.4K	0.02%	1056
2022 Q2	$107K	Buy	+21,687	New	+$120K	﹤0.01%	1725
2021 Q1	–	Sell	-34,200	Closed	-$615K	–	2181
2020 Q4	$615K	Sell	34,200 -14,097	-29%	-$211K	0.03%	853
2020 Q3	$558K	Buy	+48,297	New	+$797K	0.03%	939

Other funds holding GTHX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Engineers Gate Manager's GTHX Position: Q1 2024 in Review

Engineers Gate Manager sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2024, closing a stake of 44,639 shares — an estimated $136K sold.

Engineers Gate Manager first reported a position in GTHX in Q3 2020 and held it in 7 quarters. The position peaked at $615K in Q4 2020. 86 funds tracked by Wall St. Rank hold GTHX as of Q1 2024.

Engineers Gate Manager reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Engineers Gate Manager sold 44,639 G1 Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $136K.
Engineers Gate Manager first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Engineers Gate Manager's G1 Therapeutics, Inc. Common Stock position peaked at $615K in Q4 2020.
86 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Engineers Gate Manager's 13F filing for Q1 2024, filed 15 May 2024.